Vivo Capital VIII, LLC, 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 19,364 shares at $22.00 ($418K) on 2020-02-07, disclosed to the SEC on 2020-02-11.
Open-market sale of $418k CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 157 | $3K | 0.8% |
| 2 | $22.00 | 1,134 | $25K | 6.0% |
| 3 | $22.00 | 4,614 | $102K | 24.3% |
| 4 | $21.40 | 200 | $4K | 1.0% |
| 5 | $21.40 | 1,451 | $31K | 7.4% |
| 6 | $21.40 | 5,904 |
| $126K |
| 30.2% |
| 7 | $21.40 | 5,904 | $126K | 30.2% |
| Total | $21.58 avg | 19,364 | $418K | 100% |
| Filing → |
| BPMX | SELL | 2019-06-27 | $669K | — | Filing → |
| BPMX | SELL | 2018-03-09 | $720K | — | Filing → |
| BPMX | SELL | 2017-11-13 | $119K | — | Filing → |